CHEK2 and colorectal cancer: Nevertheless, the fact that both patients in our cohort with P/LP variants in CHEK2 are younger than the mean age of diagnosis in this cohort (67 years) and both have a family history of the disease suggests that CHEK2 may predispose the Panamanian population to colorectal cancer [14].